The Insulin-Only Bionic Pancreas Improves Glycemic Control in Non-Hispanic White and Minority Adults and Children With Type 1 Diabetes
Authors' conclusion
The BP improves glycemic control in both Whites and Minorities and offers promise in decreasing health care disparities.
Study context
- Population
- Adults and children with T1D; subgroups: non-Hispanic White ("Whites", n = 240) and Black, Hispanic and other ("Minorities", n = 84)161 adults · 165 children
- Comparison
- iLet bionic pancreas vs standard of care, by race/ethnicity
Methodological detailsmulticenter, randomized controlled
- Multicenter
- Randomized controlled
Primary result
As reported in the abstract
HbA1c, mean baseline-adjusted difference, by subgroup · 13 weeks
BP vs SCMean baseline-adjusted difference, % (95% CI)P value
Whites (n = 240); −4.9 mmol/mol (−6.6 to −3.1)
−0.45(−0.61 to −0.29)
P < 0.001Minorities (n = 84); −6.0 mmol/mol (−9.2 to −2.8)
−0.53(−0.83 to −0.24)
P < 0.001Further findings
| Outcome | Mean baseline-adjusted difference (%) (95% CI) | P value | |
|---|---|---|---|
| TIR, mean baseline-adjusted difference, by subgroupBPvs SCWhites | 10 (7–12) | P < 0.001 | |
| TIR, mean baseline-adjusted difference, by subgroupBPvs SCMinorities | 14 (10–18) | P < 0.001 | |
| −1001020Difference, % (linear scale) |
Original publication
The Insulin-Only Bionic Pancreas Improves Glycemic Control in Non-Hispanic White and Minority Adults and Children With Type 1 Diabetes. Diabetes Care. Published 31 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →